Pet Imaging Of The Head And Neck An Issue Of Pet Clinics E Book

PET/CT is an integral part of the evaluation of patients who have head and neck cancer. In this issue, the state of the art in PET/CT imaging is discussed. The issue starts with an overview of FDG-PET/CT, PET and MRI for normal anatomy, including pitfalls and artifacts. This topic is followed by a review of FDG-PET/CT for initial and subsequent therapy evaluation; progressing to PET and MRI. Other articles discuss SUV as a prognostic factor in head and neck squamous cell carcinoma, PET in head and neck cancer radiotherapy treatment planning, PET in decision making for neck dissection after radiation treatment, and newer methods for improving yield from FDG-PET imaging for accurate staging, determining tumor biology, and assessing prognosis. The issue focuses on some of the most cutting-edge applications, such as new tracers PET in head and neck squamous cell carcinoma (including FLT and hypoxia imaging). PET scans in thyroid cancer is also discussed.

PET/CT is an integral part of the evaluation of patients who have head and neck cancer. In this issue, the state of the art in PET/CT imaging is discussed. The issue starts with an overview of FDG-PET/CT, PET and MRI for normal anatomy, including pitfalls and artifacts. This topic is followed by a review of FDG-PET/CT for initial and subsequent therapy evaluation; progressing to PET and MRI. Other articles discuss SUV as a prognostic factor in head and neck squamous cell carcinoma, PET in head and neck cancer radiotherapy treatment planning, PET in decision making for neck dissection after radiation treatment, and newer methods for improving yield from FDG-PET imaging for accurate staging, determining tumor biology, and assessing prognosis. The issue focuses on some of the most cutting-edge applications, such as new tracers PET in head and neck squamous cell carcinoma (including FLT and hypoxia imaging). PET scans in thyroid cancer is also discussed.

In this issue of PET Clinics, guest editor Dr. Rathan M. Subramaniam brings his considerable expertise to the topic of Head and Neck Cancers. Top experts in the field provide important updates on planning, treatment, and individual head and neck cancers, with articles such as PET/CT: laryngeal and hypopharyngeal cancers; PET/CT: thyroid cancers; PET/CT: oral cavity and oropharyngeal cancers; and more. Contains 10 relevant, practice-oriented topics including PET/CT: post-therapy follow-up in head and neck cancer; PET/CT: therapy response assessment in head and neck cancer; PET/CT: radiation therapy planning in head and neck cancer; PET/CT: nasopharyngeal cancers; and more. Provides in-depth clinical reviews on head and neck cancers, offering actionable insights for clinical practice. Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.

In this issue of Radiologic Clinics, Guest Editors Jonathan E. McConathy and Samuel J. Galgano bring their considerable expertise to the topic of PET Imaging. Top experts in the field cover key topics such as PET Imaging for lung cancer, breast cancer, melanoma, and more. Provides in-depth, clinical reviews on PET Imaging, providing actionable insights for clinical practice. Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field; Authors synthesize and distill the latest research and practice guidelines to create these timely topic-based reviews. Contains 13 relevant, practice-oriented topics including PET Imaging for hematologic malignancies, neuroendocrine tumors, prostate and genitourinary cancers, and more.

In this issue, guest editors bring their considerable expertise to this important topic. Contains 16 practice-oriented topics including fibroblast activation protein inhibitor (FAPI) PET imaging in pancreatic cancer; fibroblast activation protein inhibitor (FAPI) PET imaging in colorectal cancer; fibroblast activation protein inhibitor (FAPI) cardiac imaging; fibroblast activation protein inhibitor (FAPI) PET/CT in gastric cancer; and more. Provides in-depth clinical reviews on fibroblast activation protein imaging, offering actionable insights for clinical practice. Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.

In this issue of PET Clinics, guest editors Arman Rahmim, Babak Saboury, and Eliot Siegel bring their considerable expertise to the topic of Artificial Intelligence and PET Imaging. Provides in-depth, clinical reviews on the latest updates in AI and PET Imaging, providing actionable insights for clinical practice. Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field; Authors synthesize and distill the latest research and practice guidelines to create these timely topic-based reviews.

This issue of PET Clinics focuses on PET/MRI: Clinical Applications, and is edited by Drs. Drew Torigian and Andreas Kjaer. Articles will include: PET/MRI in Prostate Cancer; PET/MRI in Vascular Disease; PET/MRI in Lymphoma; PET/MRI in Head and Neck Cancer; PET/MRI in Brain Disease; PET/MR in Cancers of GI Tract; PET/MRI in Gynecologic Cancer; Clinical PET/MRI Systems and Patient Workflow; PET/MRI in Heart Disease; PET/MR in Breast Cancer and Lung Cancer; PET/MRI in Musculoskeletal Disorders; PET/MRI in Pediatric Oncology; Clinical PET/MRI: Future Perspectives; and more!

This issue of PET Clinics focuses on Theranostics and is edited by Drs. Ali Gholamrezanezhad and Hojjat Ahmadzadehfar. Articles will include: Good Clinical Practice for Theranostics; Theranostics in Neuroendocrine Tumors; Neuroendocrine Tumors: Imaging Perspective; Prostate Cancer Theranostics: From Target Description to Imaging; Prostate Cancer Theranostics: PSMA-targeted Therapy; Theranostics in Brain Tumors; Theranostics in Neuroblastoma; Theranostics in Thyroid Cancer; and more!